Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chin

Showing results (291-300 of 327) with videos related to

Pageof 33
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 26, 2025
Cardiovascular rate pressure product is associated with NfL in older adults at risk for ADChinenye C Odo, Joe Strong, Sarah R Lose, et al.
Journal of the American Geriatrics Society|April 1, 2022
The Wisconsin Alzheimer's Institute Dementia Diagnostic Clinic Network: A community of practice to improve dementia careMaria Mora Pinzon, Jody Krainer, Tamara LeCaire, et al.
Cell Reports|September 2, 2014
Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasisHon S Leong, Amy E Robertson, Konstantin Stoletov, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptomsLianlian Du, Rebecca E Langhough, Bruce P Hermann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementiaKarly A Cody, Lianlian Du, Rachel L Studer, et al.
Brain, Behavior, and Immunity|January 28, 2026
Higher CSF sTREM2 is related to slower hippocampal atrophy and cognitive decline independently of pTau181 levelsHenry Gilreath Stephenson, Tobey J Betthauser, Erin Jonaitis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2020
Amyloid duration is associated with preclinical cognitive decline and tau PETRebecca L Koscik, Tobey J Betthauser, Erin M Jonaitis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 18, 2022
Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's diseaseClayton J Vesperman, Rui Wang, Stephanie A Schultz, et al.
Brain : a Journal of Neurology|December 31, 2019
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-ageTobey J Betthauser, Rebecca L Koscik, Erin M Jonaitis, et al.
Clinical Chemistry|March 2, 2024
CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic ChallengesErin M Jonaitis, Beckie Jeffers, Monica VandenLangenberg, et al.
Pageof 33

Showing results (291-300 of 327) with videos related to

Sort By:
Pageof 33
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 26, 2025
Cardiovascular rate pressure product is associated with NfL in older adults at risk for ADChinenye C Odo, Joe Strong, Sarah R Lose, et al.
Journal of the American Geriatrics Society|April 1, 2022
The Wisconsin Alzheimer's Institute Dementia Diagnostic Clinic Network: A community of practice to improve dementia careMaria Mora Pinzon, Jody Krainer, Tamara LeCaire, et al.
Cell Reports|September 2, 2014
Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasisHon S Leong, Amy E Robertson, Konstantin Stoletov, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptomsLianlian Du, Rebecca E Langhough, Bruce P Hermann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementiaKarly A Cody, Lianlian Du, Rachel L Studer, et al.
Brain, Behavior, and Immunity|January 28, 2026
Higher CSF sTREM2 is related to slower hippocampal atrophy and cognitive decline independently of pTau181 levelsHenry Gilreath Stephenson, Tobey J Betthauser, Erin Jonaitis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2020
Amyloid duration is associated with preclinical cognitive decline and tau PETRebecca L Koscik, Tobey J Betthauser, Erin M Jonaitis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 18, 2022
Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's diseaseClayton J Vesperman, Rui Wang, Stephanie A Schultz, et al.
Brain : a Journal of Neurology|December 31, 2019
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-ageTobey J Betthauser, Rebecca L Koscik, Erin M Jonaitis, et al.
Clinical Chemistry|March 2, 2024
CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic ChallengesErin M Jonaitis, Beckie Jeffers, Monica VandenLangenberg, et al.
Pageof 33